Celularity Stock Performance
| CELUW Stock | USD 0.03 0.0001 0.37% |
Celularity holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.87, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Celularity will likely underperform. Use Celularity treynor ratio, as well as the relationship between the expected short fall and day median price , to analyze future returns on Celularity.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Celularity are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Celularity showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Celularity Inc. Receives Notice from Nasdaq Confirms Intention to File an Appeal - StockTitan | 10/18/2024 |
2 | Celularity Inc. Quarterly 10-Q Report - Quartz | 11/07/2024 |
3 | Celularitys Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell ... | 11/20/2024 |
4 | Acquisition by Bloom Jay R of 56053 shares of Celularity at 6.72 subject to Rule 16b-3 | 12/18/2024 |
| Begin Period Cash Flow | 28.8 M |
Celularity |
Celularity Relative Risk vs. Return Landscape
If you would invest 1.88 in Celularity on October 21, 2024 and sell it today you would earn a total of 0.83 from holding Celularity or generate 44.15% return on investment over 90 days. Celularity is currently producing 1.816% returns and takes up 15.2127% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Celularity, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Celularity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celularity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Celularity, and traders can use it to determine the average amount a Celularity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1194
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CELUW | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.21 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.82 actual daily | 36 64% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Celularity is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celularity by adding it to a well-diversified portfolio.
Celularity Fundamentals Growth
Celularity Stock prices reflect investors' perceptions of the future prospects and financial health of Celularity, and Celularity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Celularity Stock performance.
| Return On Equity | -1.54 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (2.64) % | ||||
| Operating Margin | (0.84) % | ||||
| Revenue | 22.77 M | ||||
| Gross Profit | 25.72 M | ||||
| EBITDA | (183.95 M) | ||||
| Net Income | (196.29 M) | ||||
| Cash And Equivalents | 38 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 65.42 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 2.29 X | ||||
| Book Value Per Share | 2.11 X | ||||
| Cash Flow From Operations | (38.69 M) | ||||
| Earnings Per Share | (0.87) X | ||||
| Total Asset | 143.89 M | ||||
| Retained Earnings | (841.79 M) | ||||
| Working Capital | (47.51 M) | ||||
About Celularity Performance
Evaluating Celularity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Celularity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Celularity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 150.78 | 230.82 | |
| Return On Tangible Assets | (1.80) | (1.71) | |
| Return On Capital Employed | (2.89) | (2.74) | |
| Return On Assets | (1.57) | (1.49) | |
| Return On Equity | (5.51) | (5.24) |
Things to note about Celularity performance evaluation
Checking the ongoing alerts about Celularity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Celularity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Celularity is way too risky over 90 days horizon | |
| Celularity has some characteristics of a very speculative penny stock | |
| Celularity appears to be risky and price may revert if volatility continues | |
| Celularity has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 22.77 M. Net Loss for the year was (196.29 M) with profit before overhead, payroll, taxes, and interest of 25.72 M. | |
| Celularity has accumulated about 38 M in cash with (38.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Celularity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Celularity's stock is overvalued or undervalued compared to its peers.
- Examining Celularity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Celularity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Celularity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Celularity's stock. These opinions can provide insight into Celularity's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.